Prepare for your consultation by: Documenting your current rheumatoid arthritis symptoms, disease activity, and treatment history Listing all current medications, including DMARDs, biologics, corticosteroids, and analgesics Noting any comorbidities, particularly diabetes, obesity, cardiovascular disease, or gastrointestinal conditions Being honest about your treatment goals and what has prompted interest in GLP-1 therapy Questions to discuss with your doctor : What is the current evidence for GLP-1 use in rheumatoid arthritis
Furthermore, BEC is a slow-binding inhibitor of arginase, which is still in the preclinical stage (Pudlo et al., 2017)
It may lighten skin temporarily for some time, but results vary widely, so the results are going to take time for everyone differently
However, they may end up not eating enough to properly nourish their bodies